Completed
Neisseria Meningitidis Carriage Study
What is being collected
Procedure Data
+ other Data
Collected at a single point in time - Cross-sectionalProcedureOtherDNA Samples
Who is being recruted
Bacterial Infections and Mycoses+3
+ Bacterial Infections
+ Infections
From 5 to 24 Years
+12 Eligibility Criteria
How is the trial designed
Case-Only
Examining characteristics of individuals with a disease in order to identify genetic or environmental factors contributing to the condition.Observational
Study Start: August 2013
Summary
Principal SponsorGlaxoSmithKline
Last updated: March 9, 2018
Sourced from a government-validated database.Claim as a partner
Study start date: August 2, 2013
Actual date on which the first participant was enrolled.This carriage study aims to evaluate the presence of meningococcus in Asian populations (and potential for disease) and explore the extent and serogroup distribution of meningococci circulating in the population.
Principal SponsorGlaxoSmithKline
Last updated: March 9, 2018
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
1000 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Case-only
These studies focus only on individuals who have a specific disease. Researchers examine patterns—often genetic or environmental—to uncover what might be linked to the condition.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 5 to 24 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Bacterial Infections and MycosesBacterial InfectionsInfectionsNeisseriaceae InfectionsGram-Negative Bacterial InfectionsMeningococcal Infections
Criteria
4 inclusion criteria required to participate
A male or female between, and including 5 and 24 years of age at the time of enrollment
Asymptomatic subjects attending a school or university
Subjects who the investigator believes can and will comply with the requirements of the protocol or subjects who the investigator believes that parent(s)/Legally Acceptable Representative(s) [LAR(s)] can and will comply with the requirements of the protocol
Written informed consent obtained from the subject/from the parent(s)/LAR of the subject
8 exclusion criteria prevent from participating
Acute respiratory tract infection within 14 days of sample collection
Administration of antibiotics within the 2 weeks preceding the collection of sample
Child in care
Cranio-facial malformations prohibiting the collection of posterior pharyngeal swabs
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
CompletedOne Study Center